Skip to content
POM-V Prescription Required

Terrexine DC 250mg Intramammary Suspension for Dry Cows

Active ingredient: Cephalonium

Form

Intramammary

Species

Cattle

Manufacturer

Univet Ltd

VMD MA No.

05150/5002

What it's used for

For the treatment of subclinical mastitis at drying-off caused by aureus, , , , Trueperella pyogenes, Escherichia coli and Klebsiella spp. susceptible to c...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Cephalonium

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Terrexine DC 250mg Intramammary Suspension for Dry Cows — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the treatment of subclinical mastitis at drying-off caused by
aureus, , , ,
Trueperella pyogenes, Escherichia coli and Klebsiella spp. susceptible to cefalonium.
Do not use in cases of hypersensitivity to cephalosporins, other ß-lactam antibiotics
or to any of the excipients.
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Hypersensitivity reactions (restlessness, tremor,
swelling of mammary gland, eyelids and lips)
1
Immediate reactions observed in some animals which can lead to death.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
None.

Special precautions for use in animals
Use of the veterinary medicinal product should be based on identification and
susceptibility testing of the target pathogens.

Revised: November 2024
AN: 01334/2023 - 01709/2023 – 01932/2024
If this is not possible, therapy should be based on epidemiological information and
knowledge of susceptibility of the target pathogens at farm level, or at local/regional
level.
Use of the veterinary medicinal product should be in accordance with official, national
and regional antimicrobial policies.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach.
Use of the veterinary medicinal product deviating from the instructions given in the
SPC may increase the prevalence of bacteria resistant to cefalonium and may
decrease the effectiveness of treatment with other beta lactams.
Dry cow therapy protocols should take local and national policies on antimicrobial
use into consideration, and undergo regular veterinary review.
The feeding of waste milk containing residues of cefalonium to calves should be
avoided up to the end of the milk withdrawal period (except during the colostral
phase), because it could select antimicrobial-resistant bacteria within the intestinal
microbiota of the calf and increase the faecal shedding of these bacteria.
The efficacy of the veterinary medicinal product is only established against the
pathogens mentioned in Section 4.2 Indications for use for each target species.
Consequently, serious acute mastitis (potentially fatal) due to other pathogen
species, particularly , can occur after drying off. Good
hygienic practices should be thoroughly respected in order to reduce this risk.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Penicillin and cephalosporins may cause sensitisation (allergy) following injection,
inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross-
sensitivity to cephalosporin and vice versa. Allergic reactions to these substances
may occasionally be serious.
Do not handle this veterinary medicinal product if you know you are sensitised, or if
you have been advised not to work with such preparations.
Handle this veterinary medicinal product with great care to avoid exposure, taking all
recommended precautions.
If you develop symptoms following exposure such as a skin rash you should seek
medical advice and show the package leaflet or the label to the physician. Swelling of
the face, lips or eyes or difficulty breathing are more serious symptoms and require
urgent medical attention.
Wash hands after use.
The cleaning towels provided with the intramammary veterinary medicinal product
contain isopropyl alcohol.

Revised: November 2024
AN: 01334/2023 - 01709/2023 – 01932/2024
Wear protective gloves if skin irritation due to isopropyl alcohol is known or
suspected. Avoid contact with eyes because isopropyl alcohol can cause eye
irritation.
Special precautions for the protection of the environment
Not Applicable.
Other precautions
Not Applicable.
Cephalosporins should not be administered concurrently with bacteriostatic
antimicrobials. Concomitant use of cephalosporins and nephrotoxic drugs may
increase renal toxicity.
Do not store above 25°C.
phase), because it could select antimicrobial-resistant bacteria within the intestinal
microbiota of the calf and increase the faecal shedding of these bacteria.
The efficacy of the veterinary medicinal product is only established against the
pathogens mentioned in Section 4.2 Indications for use for each target species.
Consequently, serious acute mastitis (potentially fatal) due to other pathogen
species, particularly , can occur after drying off. Good
hygienic practices should be thoroughly respected in order to reduce this risk.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Penicillin and cephalosporins may cause sensitisation (allergy) following injection,
inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross-
sensitivity to cephalosporin and vice versa. Allergic reactions to these substances
may occasionally be serious.
Do not handle this veterinary medicinal product if you know you are sensitised, or if
you have been advised not to work with such preparations.
Handle this veterinary medicinal product with great care to avoid exposure, taking all
recommended precautions.
If you develop symptoms following exposure such as a skin rash you should seek
medical advice and show the package leaflet or the label to the physician. Swelling of
the face, lips or eyes or difficulty breathing are more serious symptoms and require
urgent medical attention.
Wash hands after use.
The cleaning towels provided with the intramammary veterinary medicinal product
contain isopropyl alcohol.

Revised: November 2024
AN: 01334/2023 - 01709/2023 – 01932/2024
Wear protective gloves if skin irritation due to isopropyl alcohol is known or
suspected. Avoid contact with eyes because isopropyl alcohol can cause eye
irritation.
Special precautions for the protection of the environment
Not Applicable.
Other precautions
Not Applicable.
4.6 Adverse reactions (frequency and seriousness)
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Hypersensitivity reactions (restlessness, tremor,
swelling of mammary gland, eyelids and lips)
1
Immediate reactions observed in some animals which can lead to death.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
4.7 Use during pregnancy, lactation or lay
Pregnancy:
The veterinary medicinal product is intended for use during the last trimester of
pregnancy once the lactating cow has been dried off. There is no adverse treatment
effect on the foetus.
Lactation:
The veterinary medicinal product must not be used in cows that are lactating.
4.8 Interaction with other medicinal products and other forms of interaction
Cephalosporins should not be administered concurrently with bacteriostatic
antimicrobials. Concomitant use of cephalosporins and nephrotoxic drugs may
increase renal toxicity.
4.9 Amount(s) to be administered and administration route
For intramammary use.
The intramammary syringe must only be used once.
The contents of one intramammary syringe should be infused into the teat canal of
each quarter immediately after the last milking of the lactation. Do not bend the
nozzle. Avoid contamination of the nozzle after removing the cap. Before infusion,
the teat should be thoroughly cleaned and disinfected (e.g. with the cleaning towel
provided).

Revised: November 2024
AN: 01334/2023 - 01709/2023 – 01932/2024
Option 1: For short nozzle intramammary administration hold the barrel of the
intramammary syringe and the base of the cap in one hand and twist off the small
upper part of the cap above the indent mark (the base portion of the cap remains on
the intramammary syringe). Take care not to contaminate the nozzle.
Option 2: For full nozzle intramammary administration remove the cap fully by holding
the barrel of the intramammary syringe firmly on one hand and with the thumb push
up and along the length of the cap until the cap clicks off. Take care not to
contaminate the nozzle.
Insert the nozzle into the teat canal and apply steady pressure on the intramammary
syringe plunger until the full dose has been delivered. Holding the end of the teat with
one hand, gently massage upwards with the other to aid dispersion of the antibiotic
into the quarter.

Revised: November 2024
AN: 01334/2023 - 01709/2023 – 01932/2024
After infusion it is advisable to dip the teats in an antiseptic preparation specifically
designed for this purpose.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Repeated doses in cattle on three consecutive days did not demonstrate or produce
any adverse effects.
4.11 Withdrawal periods
Meat and offal: 21 days.
Milk: 96 hours after calving if the dry period is longer than 54 days.
58 days following the treatment if the dry period is less than or equal to 54 days.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.